Dihydrocodeine BPM Phenyleph HCl and Ranibizumab Intraocular
Determining the interaction of Dihydrocodeine BPM Phenyleph HCl and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: brompheniramine / dihydrocodeine / phenylephrine
Brand name:
Synonyms: n.a.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dihydrocodeine BPM Phenyleph HCl-Ranibizumab ophthalmic
- Dihydrocodeine BPM Phenyleph HCl-Ranitidine
- Dihydrocodeine BPM Phenyleph HCl-Ranitidine Capsule
- Dihydrocodeine BPM Phenyleph HCl-Ranitidine Hydrochloride
- Dihydrocodeine BPM Phenyleph HCl-Ranitidine Injection
- Dihydrocodeine BPM Phenyleph HCl-Ranitidine Suspension
- Ranibizumab Intraocular-Dihydrocodeine, Aspirin, and Caffeine
- Ranibizumab Intraocular-Dihydroergotamine
- Ranibizumab Intraocular-Dihydroergotamine injection
- Ranibizumab Intraocular-Dihydroergotamine Mesylate
- Ranibizumab Intraocular-Dihydroergotamine nasal
- Ranibizumab Intraocular-Dihydroergotamine Nasal Spray